S.Korean consortium to produce 100 mln doses a month of Russia's Sputnik V vaccine

Humedix Co

16/04/2021 03:41

By Sangmi Cha
    SEOUL, April 16 (Reuters) - South Korea's Huons Global Co
Ltd  084110.KQ  said on Friday it will lead a consortium to
produce 100 million doses of Russia's Sputnik V COVID-19 vaccine
per month as Moscow ramps up production for supplies abroad.
    The announcement comes after South Korean biotech firm GL
Rapha signed a deal with Russia's sovereign wealth fund late
last year to make more than 150 million doses of Sputnik V per
year.  urn:newsml:reuters.com:*:nL1N2HZ0A4
    Huons said the consortium will begin producing sample
batches in August and respond flexibly to supply demands from
the Russian Direct Investment Fund (RDIF).
    The consortium includes three other local companies -
Prestige BioPharma  950210.KS , Humedix  200670.KQ  and Boran
Pharma - which will build a new production facility, Huons said
in a statement.
    Shares in Huons Global jumped 29.8% to their daily limit on
Friday morning trade, versus a flat wider market  KS11. .
    India's ambassador to Moscow on Friday said deliveries of
Russia's Sputnik V coronavirus vaccine to India were expected to
begin before the end of April, after Indian regulators approved
the shot for use on Monday.  urn:newsml:reuters.com:*:nR4N2FR03Z
    The European Medicines Agency (EMA) is conducting a rolling
review of the Russian vaccine as many European countries seek to
ramp up inoculation programmes that have been hampered by
delivery delays.  urn:newsml:reuters.com:*:nL8N2M85P3

 (Reporting by Sangmi Cha, Additional reporting by Joyce Lee;
Editing by Lincoln Feast.)
 ((Sangmi.Cha@thomsonreuters.com; +82 2 3704 5646; Reuters
Messaging: sangmi.cha.thomsonreuters.com@reuters.net))